Question 1

What is the share price of Alivus Life Sciences Limited today?

Accepted Answer

Alivus Life Sciences Limited (ALIVUS) is trading at ₹1,397.4. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is ALIVUS’s P/E ratio versus the sector?

Accepted Answer

ALIVUS trades at a P/E of 26.4. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is ALIVUS’s dividend yield?

Accepted Answer

ALIVUS has a dividend yield of 0.37%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is ALIVUS’s 52-week high and low?

Accepted Answer

ALIVUS has traded between ₹819 and ₹1,493.8 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Alivus Life Sciences Limited?

Accepted Answer

Alivus Life Sciences Limited has a market capitalisation of ₹16,417 crore.

Question 6

What is ALIVUS’s return on equity?

Accepted Answer

ALIVUS reports a return on equity of 17.9%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.

Question 7

Who are ALIVUS’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is ALIVUS’s promoter holding?

Accepted Answer

Promoters hold 74.87% of ALIVUS. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include ALIVUS?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight ALIVUS carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Alivus Life Sciences Limited a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from ALIVUS’s own numbers. The judgement is yours.

Revenue	₹2,552 crore
Net profit	₹564 crore
Operating margin	31%
EPS	₹45.99

ALIVUS

ALIVUS

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

ALIVUS financial summary